Medicare beneficiary panel characteristics associated with high Part D biologic disease-modifying anti-rheumatic drug prescribing for older adults among rheumatologists.
dc.contributor.author | Lee, Jiha | |
dc.contributor.author | Chang, Chiang-Hua | |
dc.contributor.author | Yung, Raymond | |
dc.contributor.author | Bynum, Julie PW | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2021-10-20T20:25:58Z | |
dc.date.available | 2021-10-20T20:25:58Z | |
dc.date.issued | 2021-04-23 | |
dc.identifier.issn | 0025-7974 | |
dc.identifier.issn | 1536-5964 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/33879745 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/170715 | en |
dc.description.abstract | ABSTRACT: The aim of this study was to investigate beneficiary panel characteristics associated with rheumatologists' prescribing of biologic DMARDs (bDMARDs) for older adults.In this retrospective observational study, we used Medicare Public Use Files (PUFs) to identify rheumatologists who met criteria for high-prescribing, defined as bDMARD prescription constituting ≥20% of their DMARD claims for beneficiaries ≥65 years of age. We first used descriptive analysis then multivariable regression model to test the association of high prescribing of bDMARDs with rheumatologists' panel size and beneficiary characteristics. In particular, we quantified the proportion of panel beneficiaries ≥75 years of age to assess how caring for an older panel correlate with prescribing of bDMARDs.We identified 3197 unique rheumatologists, of whom 405 (13%) met criteria for high prescribing of bDMARDs for Medicare beneficiaries ≥65 years of age. The high-prescribers provided care to 12% of study older adults, and yet accounted for 21% of bDMARD prescriptions for them. High prescribing of bDMARDs was associated with smaller panel size, and their beneficiaries were more likely to be non-black, ≥75 years of age, non-dual eligible, have diagnosis of CHF, however, less likely to have CKD.Rheumatologists differ in their prescribing of bDMARDs for older adults, and those caring for more beneficiaries ≥75 years of age are more likely to be high-prescribers. Older adults are more prone to the side-effects of bDMARDs and further investigation is warranted to understand drivers of differential prescribing behaviors to optimize use of these high-risk and high-cost medications. | |
dc.format.medium | ||
dc.language | eng | |
dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
dc.relation.haspart | ARTN e25644 | |
dc.rights | Licence for published version: Creative Commons Attribution-NonCommercial 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | Aged | |
dc.subject | Aged, 80 and over | |
dc.subject | Antirheumatic Agents | |
dc.subject | Arthritis, Rheumatoid | |
dc.subject | Biological Products | |
dc.subject | Drug Prescriptions | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Medicare Part D | |
dc.subject | Practice Patterns, Physicians' | |
dc.subject | Retrospective Studies | |
dc.subject | Rheumatologists | |
dc.subject | United States | |
dc.title | Medicare beneficiary panel characteristics associated with high Part D biologic disease-modifying anti-rheumatic drug prescribing for older adults among rheumatologists. | |
dc.type | Article | |
dc.identifier.pmid | 33879745 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/170715/2/Medicare beneficiary panel characteristics associated with high Part D biologic disease-modifying anti-rheumatic drug prescr.pdf | |
dc.identifier.doi | 10.1097/md.0000000000025644 | |
dc.identifier.doi | https://dx.doi.org/10.7302/3632 | |
dc.identifier.source | Medicine | |
dc.description.version | Published version | |
dc.date.updated | 2021-10-20T20:25:55Z | |
dc.identifier.volume | 100 | |
dc.identifier.issue | 16 | |
dc.identifier.startpage | e25644 | |
dc.identifier.name-orcid | Lee, Jiha | |
dc.identifier.name-orcid | Chang, Chiang-Hua | |
dc.identifier.name-orcid | Yung, Raymond | |
dc.identifier.name-orcid | Bynum, Julie PW | |
dc.working.doi | 10.7302/3632 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.